NanoRepro AGXTER:NN6 -2.54%51 Quick Ratio is 30.67 as of Jun. 2025, which is 64% above its 10-year median of 18.69. GuruFocus rates XTER:NN6 with a GF Score™ of 51/100 and a GF Value™ of €1.00 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, NanoRepro AG ranks better than 99.07% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. NanoRepro AG's quick ratio for the quarter that ended in Jun. 2025 was 30.67.
NanoRepro AG has a quick ratio of 30.67. It generally indicates good short-term financial strength.
The historical rank and industry rank for NanoRepro AG's Quick Ratio or its related term are showing as below:
XTER:NN6'
s Quick Ratio Range Over the Past 10 Years
Min: 3.77 Med: 18.69 Max: 72.87
Current: 30.67
During the past 13 years, NanoRepro AG's highest Quick Ratio was 72.87. The lowest was 3.77. And the median was 18.69.
XTER:NN6's Quick Ratio is ranked better than 99.07% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.715
vs XTER:NN6: 30.67
NanoRepro AG (XTER:NN6) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
NanoRepro AG Quick Ratio Related Terms
NanoRepro AG Quick Ratio Historical Data
* Premium members only.
The historical data trend for NanoRepro AG's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:NN6 vs TMO, DHR, IDXX: Quick Ratio Comparison
For the Diagnostics & Research subindustry, NanoRepro AG's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NanoRepro AG Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, NanoRepro AG's Quick Ratio distribution charts can be found below:
* The bar in red indicates where NanoRepro AG's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
NanoRepro AG's Quick Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NanoRepro AG (XTER:NN6) has a Quick Ratio of 30.67 as of Jun. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on NanoRepro AG and its competitors. This is 64% above median its historical median of 18.69. Over the past decade, NanoRepro AG's Quick Ratio has ranged from 3.77 to 72.87. According to the industry distribution chart, NanoRepro AG ranks #2 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 0.90000000000001%.
Is NanoRepro AG's Quick Ratio too high?
NanoRepro AG's current Quick Ratio of 30.67 is 64% above median its 10-year median of 18.69. Over the past 10 years, this metric has ranged from a low of 3.77 to a high of 72.87. The Medical Diagnostics & Research industry median Quick Ratio is 1.72. NanoRepro AG's value of 30.67 is 1688.3% above this industry median. Based on the distribution chart, NanoRepro AG ranks #2 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, NanoRepro AG has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NanoRepro AG's Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, NanoRepro AG ranks #2 out of 214 companies for Quick Ratio. This places NanoRepro AG in the top 1% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.72. NanoRepro AG's value of 30.67 is 1688.3% above this benchmark. Historically, NanoRepro AG's own Quick Ratio has ranged from 3.77 to 72.87 over the past decade. While the company's 10-year median is 18.69 vs. the industry median of 1.72, NanoRepro AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.72, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NanoRepro AG's current Quick Ratio of 30.67 is 1688.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on NanoRepro AG and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NanoRepro AG's current Quick Ratio is 30.67, which is 64% above median its own 10-year median of 18.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NanoRepro AG stock overvalued right now?
Based on GuruFocus' analysis, NanoRepro AG (XTER:NN6) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.00, compared to a current price of €1.92 — trading 91.5% above its estimated fair value. The current Quick Ratio is 30.67, which is 64% above median its 10-year median of 18.69 and 1688.3% above the Medical Diagnostics & Research industry median of 1.72. NanoRepro AG's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For NanoRepro AG (XTER:NN6), the current Quick Ratio is 30.67 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NanoRepro AG (XTER:NN6) Overvalued in 2026?
Based on GuruFocus' analysis, NanoRepro AG stock appears to be overvalued.
The current stock price of €1.92 is trading 91.5% above its estimated GF Value™ of €1.00.
GuruFocus considers NanoRepro AG to be Significantly Overvalued.
Key valuation signals for XTER:NN6:
Quick Ratio: 30.67 (64% above median its 10-year median of 18.69)
GF Value™: €1.00 vs. price of €1.92 (91.5% above fair value)
Industry Position: 1688.3% above the Medical Diagnostics & Research median (#2 of 214)
No single metric tells the full story. See the XTER:NN6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
51GF Score
Get the complete analysis for XTER:NN6
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:NN6 has been successfully added to your 
